Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Nuformix Plc (NFX) Share Price & Analysis

NFX Stock Chart & Stats

GBX 0.10-GBX 0.01(-4.76%)
At close: 3:57 PM GMT
0.1 p0.125 p0.15 p0.175 p3 Aug17 Aug1 Sep14 Sep28 Sep12 Oct26 Oct
Day’s Range
GBX 0.10 - GBX 0.11
52-Week Range
GBX 0.09 - GBX 0.56
Previous Close
GBX 0.11
Volume
N/A
Average Volume (3M)
19.79M
Market Cap
GBP 2.74M
Enterprise Value
GBP 2.97T
Total Cash (Recent Filing)
GBP 930.28K
Total Debt (Recent Filing)
GBP 0
Price to Earnings (P/E)
―
Beta
-0.23
Next Earnings
Feb 03, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

The absence of debt reduces interest obligations and refinancing exposure, giving Nuformix greater flexibility to allocate scarce resources toward drug development. This provides some financial resilience over the next several quarters, although the small asset base still limits the overall buffer.

Focused Inhaled-therapy Pipeline

A focused pipeline built around inhaled delivery and repurposed drugs gives Nuformix a defined scientific strategy rather than a broad, unfocused portfolio. Improving lung delivery and reducing systemic side effects could support differentiation if development results validate the approach.

Lower Recent Loss

The substantial reduction in reported net loss indicates that spending or other cost pressures were lower in 2025, improving near-term financial control. If maintained, this could extend the company’s operating runway, though it has not yet produced profitability or revenue growth.

Bears Say

No Recent Revenue

Persistent zero revenue shows that Nuformix has not yet established a commercial income base, leaving its economic model dependent on future clinical progress and partnering outcomes. Without product or licensing revenue, funding development and creating shareholder value remain uncertain.

Persistent Cash Burn

Negative operating and free cash flow indicates that the business continues to consume cash rather than finance development internally. Ongoing burn can force reliance on external funding, potentially limiting strategic flexibility and creating dilution or financing pressure over the next several quarters.

Shrinking Financial Base

The sharp reduction in equity and assets leaves Nuformix with a smaller financial cushion against further development costs or operating losses. Although debt is absent, the reduced balance-sheet scale makes the company more vulnerable to funding needs and setbacks in its pipeline.

Nuformix Plc News

NFX FAQ

What was Nuformix Plc’s price range in the past 12 months?
Nuformix Plc lowest share price was 0.09 p and its highest was 0.56 p in the past 12 months.
What is Nuformix Plc’s market cap?
Nuformix Plc’s market cap is £2.74M.
When is Nuformix Plc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nuformix Plc’s earnings last quarter?
Nuformix Plc released its earnings results on May 28, 2026. The company reported 0 p earnings per share for the quarter.
Is Nuformix Plc overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nuformix Plc pay dividends?
Nuformix Plc does not currently pay dividends.
What is Nuformix Plc’s EPS estimate?
Nuformix Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuformix Plc have?
Nuformix Plc has 2,609,750,000 shares outstanding.
What happened to Nuformix Plc’s price movement after its last earnings report?
Nuformix Plc reported an EPS of 0 p in its last earnings report. Following the earnings report the stock price went down -2.941%.
Which hedge fund is a major shareholder of Nuformix Plc?
Currently, no hedge funds are holding shares in GB:NFX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology